Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Scientists develop environmental justice lens to identify neighborhoods vulnerable to climate change
A new capability to identify urban neighborhoods, down to the block and building level, that are most vulnerable to climate change could help ensure that mitigation and resilience programs reach the people who need them the most.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
How an Alvin M. Weinberg Fellow is increasing security for critical infrastructure components
It’s a simple premise: To truly improve the health, safety, and security of human beings, you must first understand where those individuals are.
Tackling the climate crisis and achieving an equitable clean energy future are among the biggest challenges of our time.
Unequal access to modern infrastructure is a feature of growing cities, according to a study published this week in the Proceedings of the National Academy of Sciences
ORNL scientists had a problem mapping the genomes of bacteria to better understand the origins of their physical traits and improve their function for bioenergy production.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.